PharVision Advisers’s Nokia NOK Stock Holding History

PharVision Advisers’s Portfolio NOK Stock Details NOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,307	Closed	-$82.9K	–	105
2026 Q1	$82.9K	Buy	+10,307	New	+$75.7K	0.84%	62

Other funds holding NOK

Nvidia Corp Santa Clara, California $63.4B AUM 136.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PharVision Advisers's NOK Position: Q2 2026 in Review

PharVision Advisers sold out of Nokia (NOK) in Q2 2026, closing a stake of 10,307 shares — an estimated $82.9K sold.

PharVision Advisers first reported a position in NOK in Q1 2026 and held it in 1 quarter. The position peaked at $82.9K in Q1 2026. 790 funds tracked by Wall St. Rank hold NOK as of Q2 2026.

PharVision Advisers reported no remaining Nokia position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 10,307 Nokia shares in Q2 2026, an estimated $82.9K.
PharVision Advisers first reported a position in Nokia in Q1 2026 and held it in 1 quarter.
PharVision Advisers's Nokia position peaked at $82.9K in Q1 2026.
790 funds tracked by Wall St. Rank held Nokia as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.